#molecular diagnostics laboratory in Pune | Explore Tumblr posts and blogs

ctnursinghome1111 · 24 days ago

Text

Pathology Lab Services in Dhanori Pune - CT Nursing Home

At CT Nursing Home, we understand the importance of accurate and timely diagnostic results in ensuring the best possible healthcare outcomes. Our pathology lab services in Dhanori, Pune, are designed to provide you with comprehensive and reliable diagnostic solutions.

Pathology Lab Services in Dhanori, Pune:

Our pathology lab is equipped with state-of-the-art technology and staffed by experienced pathologists and technicians. We offer a wide range of pathology lab services, including:

Blood Tests: Complete Blood Count (CBC), Blood Chemistry, and other specialized tests.

Urine Tests: Urine Routine, Urine Microscopy, and Urine Culture.

Tissue and Cell Analysis: Histopathology, Cytopathology, and Molecular Pathology.

Microbiology Tests: Bacterial Cultures, Fungal Cultures, and Viral Tests.

Immunology Tests: Autoimmune Disorder Tests and Allergy Tests.

CT Nursing Home in Dhanori offers special discounts and packages for pathology tests. They have a dedicated pathology lab that follows a stringent quality control system and provides internationally accepted quality diagnostic services. The lab offers a range of tests, including blood tests, urine tests, and tests on stools and bodily tissues.

Our Clinic provides discounts and packages for various pathology tests, ensuring that patients receive accurate and reliable diagnostic results at affordable prices. We are committed to providing you with the best possible healthcare outcomes through our comprehensive pathology lab services in Dhanori, Pune. CT Nursing Home Best Pathology Lab in Pune Under the supervision of a qualified pathologist, the Laboratory follows a stringent quality control system.

#BestPaediatricHospitalNearMe #General Surgery Hospital in Dhanori #Sonography Services In Dhanori #BestInfertilitySpecialistInDhanori #Color Doppler Services In Dhanori #Top Maternity Hospital in Dhanori #Maternity Hospital in Dhanori #Pathology Lab Services in Dhanori

0 notes

sudheervanguri · 2 months ago

Text

GeneOmbio Technologies, a leader in molecular diagnostics and life sciences research, is currently hiring a Technical Support Executive for their Pune office. Job Overview Designation: Technical Support Executive Location: Bavdhan, Pune (On-Site) Qualification: Bachelor’s in Life Sciences or a related field Experience: 1-3 years in research or testing laboratories Responsibilities of the Technical Support Executive As a Technical Support Executive, you will play a pivotal role in ensuring the seamless operation of lab processes and client services. Here are some key responsibilities: Client Support: Address technical queries from clients and provide troubleshooting assistance. Lab Operations Assistance: Support the research and testing teams in executing molecular diagnostics procedures. Documentation: Prepare and maintain accurate technical reports for internal and client use. Collaboration: Work closely with the R&D and quality control departments to ensure high-quality output. Training: Assist in the training of new staff and ensure compliance with lab safety protocols. [caption id="attachment_105798" align="aligncenter" width="640"] GeneOmbio Technologies Hiring Technical Support Executive | Pune | Life Sciences[/caption] Qualification and Skills Required The ideal candidate will have: A Bachelor’s degree in Life Sciences or a related field (e.g., Biotechnology, Microbiology). 1-3 years of experience working in research or testing laboratories. Familiarity with molecular diagnostics techniques. Strong problem-solving abilities and excellent communication skills. A detail-oriented mindset and the ability to handle multiple tasks efficiently. How to Apply Interested candidates can apply by sending their resume to [email protected]. Make sure to include "Application for Technical Support Executive" in the subject line.

0 notes

marketsandmarkets-events · 9 months ago

Text

Infectious Disease and Molecular Diagnostics Conference Promises New Trends and Insights in Diagnosis

London, March 7, 2024 - MarketsandMarkets is thrilled to announce the eagerly awaited 5th Annual Infectious Disease and Molecular Diagnostics Conference, scheduled to take place on March 21st - 22nd, 2024, at the prestigious Millennium Gloucester Hotel, located at 4-18 Harrington Gardens, London SW7 4LH. This conference promises to be a groundbreaking event, showcasing the latest trends and insights in diagnosis, as well as unveiling cutting-edge technologies that are revolutionizing the field of infectious disease and molecular diagnostics. With a focus on advancing healthcare solutions, the conference will provide a platform for industry leaders, researchers, and professionals to collaborate and discuss the most recent developments in diagnostic practices.

The Infectious Disease and Molecular Diagnostics Conference is an integral part of the renowned MarketsandMarkets DeviceCon Series 2024 - UK Edition. This series is a testament to the commitment of MarketsandMarkets in bringing together experts and innovators across various healthcare domains to share their knowledge and expertise. Register Now @ https://events.marketsandmarkets.com/5th-annual-infectious-diseases-and-molecular-diagnostics-conference/register Key highlights of the conference include: 1. New Trends and Insights in Diagnosis: Delegates can expect in-depth discussions on emerging trends, breakthroughs, and innovative approaches in the field of infectious disease and molecular diagnostics. Renowned speakers and thought leaders will share their insights, providing attendees with valuable perspectives on the latest developments. 2. Latest Technologies in Diagnosis: The conference will showcase state-of-the-art technologies that are transforming diagnostic capabilities. From advanced laboratory techniques to cutting-edge molecular diagnostic tools, participants will gain a comprehensive understanding of the latest advancements driving the future of healthcare. 3. Benefits of 'IDMD Events' in Diagnosis: The Infectious Disease and Molecular Diagnostics Conference is a unique opportunity for professionals to network, collaborate, and gain practical insights that can significantly impact their diagnostic practices. The event catalyzes knowledge exchange, fostering a community dedicated to advancing the diagnosis and treatment of infectious diseases. In addition to the Infectious Disease and Molecular Diagnostics Conference, attendees will have the chance to explore co-located events that are part of the DeviceCon Series 2024 - UK Edition, including the 8th Annual Infection Control, Sterilization & Decontamination in Healthcare Conference, 3rd Annual Minimally Invasive Surgery Conference, and 2nd Annual Next-Gen Digital Pathology Conference. Discover the Benefits: • Network with industry leaders and experts • Gain insights into the latest technologies and trends • Enhance diagnostic skills through interactive sessions • Collaborate with professionals from diverse healthcare domains Don't miss this unparalleled opportunity to be at the forefront of infectious disease and molecular diagnostics. Secure your spot now to be part of a transformative experience that promises to shape the future of healthcare. For registration and more information, please visit: https://events.marketsandmarkets.com/5th-annual-infectious-diseases-and-molecular-diagnostics-conference Contact: Vivek Tatkare MarketsandMarkets™ Conferences Tower B5, Office 101, Magarpatta SEZ Hadapsar, Pune - 411013, India: +91 20 48598285 Email: [email protected]

#healthcare #news

0 notes

analyticalmarketresearch · 11 months ago

Text

Global Molecular Diagnostics Market ,Research and Analysis by Expert: Market Size, Cost Structures and Industry Analysis 2020-2030

Overview

Global Molecular Diagnostics Market was valued at USD 8.74 billion in 2019 which is expected to reach at USD 13.58 billion by 2030 at a CAGR 8.5%. Qualiket Research provide in depth analysis of global molecular diagnostics market with latest trends, and opportunities.

Key Players:

Major Key players are listed in global molecular diagnostics market report including Abbott Laboratories, Qiagen, Illumina, Hologic, Grifols, Diasorin, Danaher Corporation, Biomérieux, Becton, Dickinson and Company,and Agilent Technologies

Request A Free Sample: https://qualiketresearch.com/request-sample/Molecular-Diagnostics-Market/request-sample

Market segmentation

The report have segmented global molecular diagnostics market according to the product and services such as Reagents & Kits, Instruments, and Software & Service, by technology such as Polymerase Chain Reaction (PCR), DNA Sequencing and NGS, Isothermal Nucleic Acid Amplification Technology, DNA Microarrays, In Situ Hybridization, and Others, by application such as Infectious Diseases, Oncology, Genetic Tests, and Others. Further, market is segmented into end user such as Hospital and Academics Laboratories, Reference Laboratories, and Others.

Read More Here: https://qualiketresearch.com/reports-details/Molecular-Diagnostics-Market

Key Features

Reagents and kits held the largest market share in 2019 and which is also fastest growing product segment due to its high adoption in research and clinical settings.

Infectious diseases is also largest revenue generating factor as molecular diagnostics provide clinicians with better substitutes to diagnose various infectious pathogens, virus, and bacteria with accurate results.

Qualiket Research report provide in depth analysis with latest market trends and key developments.

About Us:

QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers.

QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence.

QualiKet Research strive hard to simplify strategic decisions enabling you to make right choice. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition. Our experts provide deep insights which is not available publicly that enables you to take bold steps.

6060 N Central Expy #500 TX 75204, U.S.A

[email protected]

+1 214 660 5449

1201, City Avenue, Shankar Kalat Nagar,

Wakad, Pune 411057, Maharashtra, India

[email protected]

+91 9284752585

Sharjah Media City , Al Messaned, Sharjah, UAE.

[email protected]

+971 56 846 4312

0 notes

datadiscoveriesdaily · 11 months ago

Text

Veterinary Diagnostics Market Key Players, Industry Overview, Application and Analysis to 2024 to 2031

The Veterinary Diagnostics Market is a rapidly evolving sector that plays a crucial role in ensuring the health and well-being of animals. With the increasing awareness about the importance of animal healthcare, the demand for advanced diagnostic tools and technologies has witnessed a significant surge. This market encompasses a wide range of diagnostic services and products designed specifically for animals, including companion pets and livestock.

One of the key drivers propelling the growth of the Veterinary Diagnostics Market is the rising prevalence of animal diseases. The increasing incidence of infectious diseases among animals has necessitated the development of sophisticated diagnostic tools for accurate and timely detection. Additionally, the growing trend of pet ownership and the rising concern for animal health have further fueled the demand for veterinary diagnostics. Pet owners are increasingly seeking preventive and diagnostic services to ensure the well-being of their beloved companions.

Despite the promising growth prospects, the market faces certain restraints that need to be addressed for sustained development. One notable challenge is the high cost associated with advanced veterinary diagnostic procedures. The initial investment and maintenance costs of cutting-edge diagnostic equipment can be a significant barrier, particularly for smaller veterinary clinics and farmers. This cost factor poses a challenge to the widespread adoption of advanced diagnostic technologies in certain regions.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐓𝐡𝐞 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐎𝐟 𝐓𝐡𝐞 𝐑𝐞𝐩��𝐫𝐭@ https://www.sanglobalresearch.com/enquiry/veterinary-diagnostics-market

On a positive note, the Veterinary Diagnostics Market is driven by various growth factors that contribute to its expansion. Technological advancements in diagnostic imaging, molecular diagnostics, and point-of-care testing have significantly enhanced the accuracy and speed of diagnosis. Moreover, the increasing collaboration between veterinary diagnostic companies and research institutions has resulted in the development of innovative diagnostic solutions. These advancements not only improve the efficiency of diagnosis but also contribute to the overall growth of the market.

Market segment by players, this report covers

Idexx Laboratories

Abaxis

Zoetis

Qiagen

Thermo Fisher Scientific

Neogen

Heska

Virbac

Biomérieux

Randox Laboratories

Market segmentation

Market segment by Type

Service

Equipment

Reagent

Other

Market segment by Application

Veterinary Reference Laboratories

Veterinary Hospitals and Clinics

Point-of-care/In-house Testing

Research Institutes and Universities

By Geography

Our More Reports:

Digital Therapeutics Market https://www.sanglobalresearch.com/report/digital-therapeutics-market-/3107

Health Care Wastewater Treatment Market https://www.sanglobalresearch.com/report/health-care-wastewater-treatment-market-/3106

Artificial Intelligence in Cardiology Market https://www.sanglobalresearch.com/report/artificial-intelligence-in-cardiology-market/3105

Image-guided Therapy Systems Market https://www.sanglobalresearch.com/report/image-guided-therapy-systems-market-/3104

About Us:

At San Global Research Report, we pride ourselves on our commitment to quality and accuracy. Our team of experienced researchers utilizes a combination of quantitative and qualitative methods to ensure that our findings are both accurate and reliable. With a strong emphasis on responsiveness, transparency, and collaboration, we work closely with our clients to understand their objectives and deliver actionable insights. Learn more about our research approach and how it can benefit your business.

Address: Gera Imperium Rise, Phase 2 Hinjewadi, Pune, India

San Global Research | Web: http://www.sanglobalresearch.com

Direct Line: +91 9209275355

E-mail: [email protected]

#Veterinary Diagnostics Market

0 notes

karanpatil · 2 years ago

Photo

Symbiosis Institute of Health Sciences (SIHS) in Pune, India, is a leading institute for healthcare education, offering a variety of programs for students who aspire to pursue a career in the healthcare industry. One such program is the B.Sc Laboratory Technology program, which is designed to equip students with the necessary skills and knowledge to work as laboratory technicians in various healthcare settings.

The B.Sc Laboratory Technology program at SIHS is a three-year undergraduate program that covers various aspects of laboratory technology, including pathology, microbiology, biochemistry, hematology, and immunology. The program is designed to provide students with both theoretical and practical knowledge, enabling them to develop skills that are relevant to the healthcare industry.

The program curriculum at SIHS is comprehensive and covers various topics such as cell biology, anatomy, physiology, clinical laboratory techniques, and molecular biology. Students are also trained in laboratory safety and management, as well as communication skills, which are essential for effective collaboration with healthcare professionals.

The program has a strong focus on practical training, with students required to undergo extensive laboratory training, where they can develop their skills and apply the concepts learned in the classroom to real-world situations. The institute has state-of-the-art laboratories equipped with the latest technology and equipment, which allows students to gain hands-on experience with the latest techniques and technologies used in the healthcare industry.

One of the unique features of the B.Sc Laboratory Technology program at SIHS is its emphasis on research. Students are encouraged to participate in research projects and develop their research skills, which can help them pursue higher education and career opportunities in research.

Upon completion of the program, students can pursue various career options, including working as laboratory technicians in hospitals, clinics, and diagnostic laboratories. They can also pursue higher education opportunities in the field of laboratory technology or related fields.

The B.Sc Laboratory Technology program at SIHS is an excellent choice for students who aspire to pursue a career in laboratory technology and healthcare. The program curriculum, practical training, and research opportunities provide students with the necessary skills and knowledge to succeed in the healthcare industry. For more detail visit us at https://www.sihspune.org/bsc-medical-technology

#B.Sc Laboratory Technology

0 notes

sihspune20 · 2 years ago

Text

BSc and MSc MLT Courses in India: Course details, eligibility

BSc MLT course details

Bachelor of Science in Medical Laboratory Technology or BSc MLT is an undergraduate course of 3-year, it is divided into six semesters two semesters per year. In this course, students are taught about different elements of health care. The students perform different diagnostic researches on body fluids, which include hematology, bacteriology, immunologic, chemical and microscopic in the course. The subjects taught in BSc MLT colleges in Pune for the course are Clinical Endocrinology & Toxicology Lab, Diagnostic Molecular Biology Lab, Diagnostic Cytology etc.

Eligibility Criteria for BSc MLT colleges in Pune

Students who want to seek a BSc MLT course have the following eligibility criteria. The minimum marks needed in the 12th class can vary from one college to another.

The primary eligibility criteria for any BSc MLT colleges in Pune to get admission in BSc MLT course is that the prospects should have passed their 10+2 in the area of Science with compulsory subjects such as Mathematics, Physics, Chemistry and Biology.

The applicant should pass their 10+2 with a minimum of 50% marks or equivalent from the recognized education board.

Admission to BSc MLT can be either entrance based or merit-based. In the entrance-based method, students are needed to qualify for an entrance test to get admission to any college or university.

BSc MLT Syllabus

B.Sc. (Medical Laboratory Technology) course syllabus is split into 6 semesters, main subjects are Clinical Endocrinology & Toxicology Lab, Diagnostic Molecular Biology Lab, Diagnostic Cytology etc. Listed beneath is a semester-wise syllabus of the course.

Semester 1

Human Anatomy I

Human Physiology-I

Biochemistry-I

Health Education & Health Communication

PC Software Lab

Human Anatomy-I Lab

Human Physiology-I Lab

Biochemistry-I Lab

Semester 2

Human Anatomy II

Human Physiology II

Biochemistry II

Bio-Medical Waste Management

Human Anatomy-II

Practical: Human Physiology-II

Practical: Biochemistry-I

Communication Lab

SEMESTER 3

Pathology-I

Clinical Haematology-I

Microbiology-I

Immunology & Serology-I

Histopathology & Histotechniques -I

Clinical Haematology-I Lab

Microbiology, Immunology & Serology - I Lab

Histopathology & Histotechniques -I Lab

SEMESTER 4

Pathology - II

Clinical Haematology-II

Microbiology-II

Immunology & Serology-II

Histopathology & Histotechniques -II

Clinical Haematology-II Lab

Microbiology, Immunology & Serology – II Lab

Histopathology & Histotechniques -II Lab

SEMESTER 5

Immunohematology & Blood Banking

Clinical Enzymology & Automation

Parasitology & Virology

Diagnostic Cytology

Principles of Lab Management & Medical Ethics

Clinical Enzymology Lab

Parasitology & Virology Lab

Diagnostic Cytology Lab

SEMESTER 6

Clinical Endocrinology & Toxicology

Advanced Diagnostic Techniques

Diagnostic Molecular Biology

Clinical Endocrinology & Toxicology Lab

Advanced Diagnostic Techniques Lab

Diagnostic Molecular Biology Lab

Internship Project

MSc MLT Course details

MSc Medical Lab Technology is a paramedical course which works with an introduction to patient care with proper diagnosis using clinical laboratory equipment to conduct the tests. It is a 2-year postgraduate course that contains engaging subjects provided by MSc MLT colleges like molecular biology, human anatomy & physiology, biochemistry, hematology etc.

MSc MLT Eligibility Criteria

The applicants applying for the course should satisfy the specific eligibility criteria set by MSc MLT colleges, which are noted below:-

The students should have a bachelor’s degree or any equivalent degree from any government-recognized institute or university with a minimum of 55% marks.

The students who belong to ST/SC/OBC have the leisure of 5-10% for eligibility. Some of the universities also provide relaxation of the score for the students under the sports quota.

In most colleges, the MSc Lab Technology admissions are accomplished based on the results of the entrance tests.

MSc MLT Colleges in India

Symbiosis Institute of Health and Sciences, Pune

All India Institute of Medical Sciences, New Delhi

Rajiv Gandhi Institute of Paramedical Sciences, New Delhi

NIMS School of Paramedical sciences & technologies, Jaipur

MDU, Rohtak

Guru Gobind Singh Medical College & Hospital, Punjab

0 notes

greenarraylab · 2 years ago

Text

#Greenarray is a Genomic research & molecular diagnostics laboratory located in Pune #molecular diagnostic laboratory in pune #genomics company in india #laboratory #greenarray #pune #microarray system #molecular biology training course in pune #incubation centre in pune #molecular diagnostic laboratory #covid-19 rtpcr testing #Greenarray #Genomic research #molecular diagnostics laboratory in Pune #Genetic test #molecular diagnostics laboratory

0 notes

harsha112 · 5 months ago

Text

MSC Medical Technology | M sc Medical Lab Technology Colleges - SIHS Pune

When considering M.Sc Medical Lab Technology colleges in India, Symbiosis Institute of Health Sciences, Pune, emerges as a standout choice. Renowned for its excellence in healthcare education, Symbiosis Institute of Health Sciences offers a comprehensive M.Sc program in Medical Laboratory Technology (MLT). The institute provides state-of-the-art laboratories equipped with advanced diagnostic instruments, ensuring hands-on learning and practical experience for students. Faculty members are experienced professionals in the field, offering expert guidance and mentorship.

Symbiosis Institute of Health Sciences emphasizes a holistic approach to education, combining rigorous academic training with industry-relevant skills. The curriculum covers a wide range of subjects including clinical biochemistry, microbiology, hematology, immunology, and molecular diagnostics. Students benefit from workshops, seminars, and industry interactions that prepare them for successful careers in medical laboratories and healthcare settings.

Moreover, Symbiosis Institute of Health Sciences fosters a conducive environment for research and innovation, encouraging students to explore new advancements and contribute to the field of medical sciences. Graduates from the institute are well-prepared to meet the demands of the healthcare industry, equipped with both theoretical knowledge and practical skills essential for professional growth and development. Kindly visit https://www.sihs.edu.in/msc-medical-technology to know more.

#M.Sc in Cardiac Care

0 notes

hemantallied · 3 years ago

Text

Cancer Tumor Profiling Market Outlook and Opportunities in Grooming Regions

Cancer Tumor Profiling Market business research report assesses the current as well as upcoming performance of the market, and also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics.

"Cancer Tumor Profiling Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market. Analysis and discussion of important industry like market trends, size, share, growth estimates are mentioned in the report."

Download Sample Report (Get Full Insights in PDF + Pages) @ https://www.alliedmarketresearch.com/request-sample/2717

Cancer Tumor Profiling Market Research has offered exhaustive analysis of Manufacturers, Suppliers, Regions, Type and Application, Forecast to 2027. And also provides essential study on the current status of the market, cover market size with respect to valuation as sales volume and providing a precise prediction of the market scenario over the forecast period from 2020 to 2027.

The report provides revenue forecast with sales, sales growth rate, and revenue growth rate forecasts of the global Cancer Tumor Profiling Market. The forecasts are also provided with respect to the product, application, and regional segments of the market. The forecasts are provided to understand the future outlook and prospects for the market.

Major Key Players: -

The key players operating in the global cancer/tumor profiling market have adopted product launch as their key developmental strategy and have focused on launching innovative products to cater to consumer requirements and strengthen their market shares. The major companies profiled in the report include Qiagen N.V., Roche Molecular Systems Inc., Abott Molecular, Illumina Inc., NeoGenomics Laboratories, HTG Molecular Diagnostic, Genomic Health Inc., Hologic Gen-Probe, BD Biosciences, and Siemens Healthineers.

Enquiry Before Buying @ https://www.alliedmarketresearch.com/purchase-enquiry/2717

The leading companies in Global Cancer Tumor Profiling Market are analyzed in the report along with their business overview, operations, financial analysis, SWOT profile and STD Reimbursement Scenario Analysis And Top Study Testing Technologies products and services.

The key players profiled in this report include Shandong Runxin Biotechnology, Synutra Ingredients, Yantai Ruikangda Biochemical Products, TSI Group, S.A.U. Seikagaku Corporation, Sioux Pharm, Pacific Rainbow International, Summit Nutritionals International and Bioiberica.,

The report lays emphasis on the key trends and opportunities that may emerge in the near future and positively impact the overall industry growth. Additionally, challenges and restraining factors that are likely to curb the growth in the years to come are put forth by the analysts to prepare the manufacturers for future challenges in advance.

Request for Customization of This Report @ https://www.alliedmarketresearch.com/request-for-customization/2717

COVID-19 scenario:

The outbreak of the COVID-19 pandemic led to disruptions in the whole supply chain, leading to difficulty in the supply of raw materials and finished goods. However, the disruptions were rectified by the second half of the year 2020, thereby, the market recovered soon.

The online sales channels have gained high traction in the last year. And as a result players operating in the industry are strengthening their digital presence. The report offers detailed segmentation of the global shavers market based on type, demographics, nature, sales channel, and region.

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa

Portland, OR, United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975

[email protected]

Web: https://www.alliedmarketresearch.com

0 notes

avini24513 · 3 years ago

Text

U.S. Genetic Testing Market Size, Share, Growth and 2027 Forecast Report

US Genetic Testing Market Size| 2021 Covid-19 Impact On Automotive Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2026 is latest study published by Fortune Business Insights. The US Genetic Testing Market size is expected to gain momentum by reaching USD 10.29 billion by 2027 while exhibiting an impressive CAGR of 13.0% between 2020 and 2027. This information is published by Fortune Business Insights in its latest report, titled, “U.S. Genetic Testing Industry, 2020-2027.” The report further mentions that the market stood at USD 4.11 billion in 2019. Factors such as increasing prevalence of chronic disorders and the increasing awareness regarding the efficacy of genetic testing in the U.S. will contribute to the growth of the market during the forecast period.

For More Information in the Analysis of Report: https://www.fortunebusinessinsights.com/u-s-genetic-testing-market-105034

Increasing Prevalence of Chronic Disorders to Augment Growth

According to the Centers for Disease Control and Prevention (CDC), chronic ailments such as cancer, heart disorders, and diabetes are the leading cause of disability and deaths of people across the U.S. Moreover, the U.S. healthcare system suffers an estimated USD 320 billion annually, in direct and indirect costs. Therefore, to reduce the healthcare costs, several healthcare companies contemplate offering advanced screening solutions to detect the disease at the preliminary stage and further prevent disease fatality. Moreover, increasing awareness regarding the efficacy of the genetic testing methods amongst the healthcare professionals is expected to favor the US Genetic Testing Market growth in the forthcoming years.

What does the Report Provide?

The market report provides a qualitative and quantitative analysis of the market and focuses on key aspects such as the regulatory overview, key industry developments such as mergers, acquisitions, and partnerships, and funding raised by start-up companies that will impact the market. Additionally, the report offers valuable insights into the latest market trends and highlights key industry dynamics by adopting several research methodologies during the forecast period.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/u-s-genetic-testing-market-105034

List of the Companies Profiled in the Market:

Invitae Corporation (San Francisco, U.S.)

Ambry Genetics (Aliso Viejo, U.S.)

BioReference Laboratories, Inc. (Elmwood Park, U.S.)

Progenity, Inc. (San Diego, U.S.)

Quest Diagnostics Incorporated (Secaucus, U.S.)

Myriad Genetics, Inc. (Salt Lake City, U.S.)

Fulgent Genetics (Temple City, U.S.)

Burning Rock Biotech Limited (Guangzhou, China)

Some major points from Table of Content:

Research Scope

Market Segmentation

Research Methodology

Definitions and Assumptions

Market Drivers

Market Restraints

Market Opportunities

Regulatory Overview

Overview: Funding Raised by Genetic Testing focused Start-up Companies

Key Industry Developments - Mergers, Acquisitions, and Partnership

Porter’s Five Forces Analysis

SWOT Analysis

Impact of COVID-19 Pandemic on the US Genetic Testing Market

Analysis of Transactions in the Molecular Diagnostic Clinical Laboratory Market

Overview: Personalized Medicine Market Size (USD billion), U.S., 2019

Reimbursement Scenario

PCR

DNA Sequencing

Microarrays

Others

Cardiology

Oncology

Pharmacogenomics

Cognitive Dysfunction

Pathogenomics

Others

Public Health Insurance

Private Health Insurance

Out-of-Pocket

Hospitals

Independent Laboratories

U.S. Market Share Analysis (2019)

Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based On Availability))

Invitae Corporation

Ambry Genetics

BioReference Laboratories, Inc.

Progenity, Inc.

PathemaGX

Quest Diagnostics Incorporated

Myriad Genetics, Inc.

Fulgent Genetics

Burning Rock Biotech Limited

Continued...

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-genetic-testing-market-105034

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Fortune Business Insights™ Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India.

Phone: US :+1 424 253 0390 UK : +44 2071 939123 APAC : +91 744 740 1245 Email: [email protected] Fortune Business Insights™ LinkedIn | Twitter | Blogs

#U.S. Genetic Testing Market Size

1 note · View note

swarajya7793 · 3 years ago

Text

Significant COVID-19 Impact on Immunoassay | Healthcare Industry | Data Bridge Market Research

COVID-19 Impact on Immunoassay in the Healthcare Industry

The outbreak of coronavirus highlights the need of rapid and effective test method in order to detect and identify the target virus.

WHO has validated two types of test for detection of COVID 19 one is molecular diagnostic test and other one is immunological assay test. But as molecular diagnostic test such as PCR among others cannot be used for monitoring of disease progressing stage, there is a great need of immunological assays.

The development of rapid test method such as immunoassay among others has become an urgent need for effective drug and vaccine development so as to curtail the spread of COVID 19.

Price Impact:

The need of immunoassay kit for reliable COVID 19 test led the country’s government to reduce the price of these tests, so that individual belonging to any economic status can afford such tests.

Moreover some of the immunoassay kits were imported from different regions of the world, however due to ban and lockdown across borders import of testing kits also stopped. Along with this, the manufacturing of immunoassay kits in the country itself has also caused price reduction.

Immunoassay tests in order to recognize the viral antigen and related immunoglobulin are free at government laboratories, which again caused price reduction of kits.

For instance:

· The charges fixed by ICMR at private labs for immunoassay test is USD (Indian Rupees 4,500).

Thus, it signifies that due to COVID 19 pandemic, the price of immunoassays kits and related products will reduce but product sales will increase.

Impact on Demand

This has been reported that RT-PCR based viral RNA detection test are widely used for diagnosis of COVID-19, however in order to monitor the progress of disease and identification of different stages there is a great need of immunological assays.

The results provided by immunological tests have an important role in vaccine development, which again increases the demand of immunoassay test.

Lateral flow immunoassay is one of the rapid diagnostic tests used for detection of viral antigens within 10-30 minutes. Moreover this is an inexpensive test and does not require any trained personnel for performing the test. All such factors again enhance the demand of immunoassay tests.

ELISA test can also be used for detection of viral components. ELISA is compatible with various kinds of samples that increase its demand for COVID 19 test. Moreover it is suitable for point of care detection.

Luminescent immunoassay has been reported in excessive use for COVID 19 diagnosis and manufacturers are also taking steps in order to fulfill such increasing demand.

For instance,

· Cai et al. have developed peptide- based magnetic chemiluminescence enzyme immunoassay for detection of COVID -19

Moreover increasing prevalence of COVID-19 all around the world is also responsible for increasing demand of immunoassay kits.

Figure1: Number of Laboratory Confirmed COVID-19 Cases

All these factors suggest that COVID 19 outbreak has enhanced the demand of immunoassay market.

Impact on Supply Chain:

Due to continuous COVID-19 outbreak, several restrictions have been imposed by government bodies of several countries which involves ban throughout the country’s borders among others. These restrictions led to shortage of in the supply of immunoassay kits.

While such lockdown Indian government has allowed import of certain immunoassay kits used for detection of coronavirus. As per the report published in May, 2020 Abbott Healthcare and Roche Diagnostics received approval for import of immunoassay kits. This approval involves the import of chemiluminescent immunoassay kits. This step by Indian government helped to maintain a continuous supply chain amidst the COVID-19 outbreak.

The Asian Development Bank in March 2020, decided to provide with USD 200 million for companies who are engaged in manufacturing of coronavirus related products involving immunoassay kits. This step by organization helps the company to ensure continuous supply chain of their products.

This signifies that even during the COVID-19 pandemic companies are able to maintain supply chain.

Strategic Initiatives by Manufacturers and Organizations:

Due to increasing demand of immunoassay kits across the world, the market players are launching various types of immunoassay kits.

For instance,

· In May 2020, National Institute of Virology (NIV), Pune has developed ELISA (an immunoassay test) for detection of coronavirus related antibodies in blood samples

· In April 2020, Bio-Rad announced about the launch of blood based immunoassay kit for the detection and identification of antibodies formed against SARS-CoV-2, a virus that has been reported to cause COVID-19. The company has also planned to get emergency authorization from FDA for product launch

· Roche is providing Elecsys Anti SARS CoV 2, an immunoassay used for detection of antibodies against SARS-CoV-2. The samples needed for testing antibodies involves human serum, and plasma

· In April 2020, ERBA Mannheim launched ErbaLisa COVID-19 ELISA kits for the detection of IgG and IgM antibodies formed against SARS- CoV-2. This immunoassay can be manually operated led to its enhanced usage

· In March 2020, BioMedomics, Inc., launched one of the point of care rapid immunoassay test for diagnosis of coronavirus infection. This test provides qualitative detection of IgG and IgM antibodies in human whole blood, serum and plasma. This test has initially been used by Chinese CDC but now it is available globally

This signifies that several strategic initiatives by different manufacturers in order to fight against novel coronavirus, fuel up the market growth.

As per the data provided in table large number of products available in order to perform immunoassays, this paves the way for manufacturers to earn more product sales, which again boost up the market growth.

Regulations:

Amid the COVID -19 outbreaks, various regulations associated with immunoassay test kit launch has been relaxed by FDA and other regulatory bodies due to increasing demand of rapid test for coronavirus detection.

FDA is aware of that several manufacturers are developing immunoassay test for coronavirus with an aim of submission of Emergency Use Authorization (EUA) to FDA. As the need of such test increasing, FDA is not intended for reasonable specimen testing, which consumes a lot of time.

FDA offers 15 business days to manufacturer for preparation of EUA submission for an immunoassay test whose performance has already been validated by the manufacturer.

With the urging need of worldwide population FDA has engaged with more than 100 of test developing manufacturer since the end of January and has granted EUA to several of immunoassay manufacturers.

During this pandemic FDA ensures that these test kits distribute to every labs, hospital land to other facilities which are in need of it.

Moreover FDA is working 24*7 in order to support laboratories and test developers, so that the manufacturers can distribute immunoassay test kits throughout the several countries at this urgent time.

In April, European Commission has issued a directive related to medical devices used for coronavirus testing. According to the directive launched in April if an assay meets all the requirements mentioned in directive launched by European Commission then there is no need for manufacturer to get a CE mark for that assay.

In Asia-Pacific region, after the initial outbreak of COVID 19 South Korea’s Centers for Disease Control and Prevention coordinated with the manufacturers engaged in getting approval for assay used for COVID 19 testing. Moreover in China, Singapore and Australia regulatory guidelines have been adjusted in order to get early approval and emergency use authorization for assays.

As strict regulations have been relaxed by regulatory authorities for immunoassay test kits during the COVID-19 pandemic, thus signifies that coronavirus has paved the way for the growth of immunoassay market.

Conclusion:

The pandemic of COVID 19 has led to an urgent need for the detection of coronavirus to progress the disease stage and to develop a novel vaccine, which can be possible by using immunoassay kits that provides rapid detection of antibodies formed against coronavirus. This led to the increasing demand for immunoassay kits and enhanced the growth of the immunoassay market. Various types of bans resulted in a shortage of product supplies that are expected to hamper the market growth, however, initiatives taken by the government related to product import and investment by some authorities helped the manufacturers to maintain the supply chain of immunoassay products. Increasing the prevalence of COVID-19 and the availability of immunoassay products is also expected to fuel up the market growth. Moreover, support by regulatory authorities related to approval and emergency use authorization for immunoassay products helping the market players to achieve a lucrative growth.

#Immunoassay #Immunoassay Market #Immunoassay Market Analysis #Immunoassay Market Analysis in Developed Countries #Immunoassay Market by Application #Immunoassay Market by Type #Immunoassay Market Development #Immunoassay Market Forcast #Immunoassay Market Future Innovation

0 notes

techscimarketresearch · 4 years ago

Text

Europe to Dominate Coronavirus Testing Kits Market until 2026 | TechSci Research

Growing cases of COVID-19 disease across the globe to drive the growth of global coronavirus testing kits market.

According to TechSci Research report, “Global Coronavirus Testing Kits Market By Type of Test (Molecular v/s Serological), By Use (Multiple Test v/s Single Test), By Full Test Time (5 Hours-12 Hours, 1 Hours-5 Hours, 15-60 Minutes, Less than 15 Minutes, 12 Hours-24Hours, More Than 1 Day), By Technology (RT-PCR, Rapid Diagnostic Test, ELISA Tests, Others), By Specimen Type (Nasopharyngeal specimen, Oropharyngeal specimen, Blood, Sputum, Others), By Mobility (Stationary v/s Mobile), By End Use (Public Health Labs, Hospitals, Private or Commercial Labs, Physician Labs, Others), By Region, Forecast & Opportunities, 2026”, the global coronavirus testing kits market was valued at USD50697.36 million in 2020 on account of the increasing R&D activities related to the production of coronavirus testing kits by major companies and research laboratories around the globe.

Additionally, increasing funding and grants by various governments around the globe for the development of testing kits, so that they can identify each case and take necessary preventive measures, is expected to foster the market over the next few years. Moreover, the deployment of test kits at a massive scale for testing people is anticipated to spur the market. Furthermore, increasing healthcare spending and rising need to protect the population from the outbreak are propelling the growth of the market. However, the high cost of testing kits might hamper the growth of the market, especially in developing economies. Additionally, the non-availability and shortage of testing kits might hinder the growth of the market. Besides, it has been found that some testing kits are not that efficient, which is negatively impacting market growth.

Browse 247 Figures spread through 110 Pages and an in-depth TOC on "Global Coronavirus Testing Kits Market"

https://www.techsciresearch.com/report/coronavirus-testing-kits-market/4693.html

The global coronavirus testing kits market is segmented based on type of test, use, full test time, technology, specimen type, mobility, end use, company and region. Based on type, the market can be bifurcated into molecular and serological tests. The molecular type of test segment is expected to dominate the market during the forecast period since it looks for the signs of an active infection or symptom. The specimen collected from the nasopharyngeal route is taken and sent for testing. Additionally, the sample undergoes a PCR test to find out the presence of the virus’ genetic material. The PCR confirms the diagnosis of COVID-19 if it finds two genes of the SARS-COV-2 virus. Moreover, these tests are helpful in identifying the current cases of the COVID-19 disease.

The serological tests segment is expected to witness significant growth during the forecast years since these tests are done using blood samples and detect the antibodies produced by the body against the virus. Such antibodies are present in an individual who has just recovered from COVID-19. Further, these tests are helpful in determining patients with mild or no symptoms. Based on use, the market can be divided into single test and multiple test. The multiple testing kits segment is expected to witness significant growth in the market during the next five years since they are based on community testing and are a faster and reliable method of getting results within groups of people.

Additionally, they provide faster diagnosis, are accurate, and simple & convenient to use. Based on full test time, the market can be fragmented into 5 Hours-12 Hours, 1 Hours-5 Hours,15-60 Minutes, Less than 15 Minutes,12 Hours-24 Hours, More Than 1 Day. The 5-12 hours segment is expected to dominate the market since the most preferred mode for testing, RT-PCR, generally takes this much time for the diagnosis of COVID-19. The RT-PCR test is followed by gene fingerprinting which usually takes time. The 15-60 minutes segment is also expected to witness significant growth during the forecast years because California-based molecular diagnostics company, Cepheid, has developed a rapid coronavirus diagnostic test with a detection time of about 45 minutes and has got approval from the FDA.

Also, Abbott Laboratories has developed a rapid test that will take around 5 minutes to diagnose the disease. Based on specimen type, the market can be segregated into nasopharyngeal specimen, oropharyngeal specimen, blood, sputum, and others. The nasopharyngeal specimen type is expected to dominate the market since these are the two prominent regions where the coronavirus replicates and hence are preferred for taking the patient’s specimen or sample. Also, the blood specimen type segment is expected to grow rapidly during the forecast period on account of the availability and growing preference for antibody-based testing kits, since they provide faster diagnostics of the disease. Based on end use, the market can be grouped into public health labs, hospitals, private or commercial labs, physician labs, others. The public health labs segment is expected to dominate the market owing to the presence of sophisticated diagnostic and treatment facilities they provide.

Abbott Laboratories, Altona Diagnostics GmbH, Roche Holding AG, BioMedomics Inc., Getein Biotech Inc, Hangzhou Biotest Biotech Company Ltd., AmonMed Biotechnology Co. Ltd., Beijing Tigsun Diagnostics Co Ltd., CTK Biotech Inc., Hunan Lituo Biotechnology Co. Ltd., Vivacheck Labaratories Inc., Thermo Fisher Scientific Inc., Siemens AG, Seegene Technologies Inc., FastSense Diagnostics Pvt. Ltd., Quest Diagnostics Inc., Quidel Corporation, Becton Dickinson and Company, QIAGEN N.V., PerkinElmer Inc. and others are some of the leading players operating in the global coronavirus testing kits market.

The companies operating in the market are using organic strategies such as product launches, mergers and collaborations to boost their share. For instance, in March 2020, Pune (India) based molecular diagnostic company, Mylab, became the first Indian company to have received the validation for its COVID-19 diagnostic test kits also known as the Reverse Transcription Polymerase Chain Reaction (RT-PCR) tests by the Drug Controller of India, after the National Institute of Virology validated its test. Today, the company along with companies like Altona Diagnostics and Siemens is supplying diagnostic kits to the world.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4693

Customers can also request for 10% free customization on this report.

“Asia-Pacific is expected to grow at a faster rate during forecast years since China was the epicenter of this novel coronavirus disease, hence witnessing a great demand for the testing kits. Additionally, many other countries in the region along with China have already developed their testing kits and are supplying them to the world. For instance, in March 2020, Seegene, a South Korean company, announced that Los Angeles, Government of U.S., has purchased 20,000 corona test kits from Seegene Technologies. Mylab (India) is also supplying kits to the world. Also, Japan Kurabo Industries Ltd., has apparently launched a new range of testing kits which are expected to give results within 15 minutes.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Global Coronavirus Testing Kits Market By Type of Test (Molecular v/s Serological), By Use (Multiple Test v/s Single Test), By Full Test Time (5 Hours-12Hours, 1 Hours-5 Hours,15-60Minutes, Less than 15 Minutes,12 Hours-24Hours, More Than 1 Day), By Technology (RT-PCR, Rapid Diagnostic Test, ELISA Tests, Others), By Specimen Type (Nasopharyngeal specimen, Oropharyngeal specimen, Blood, Sputum, Others), By Mobility (Stationary v/s Mobile), By End Use (Public Health Labs, Hospitals, Private or Commercial Labs, Physician Labs, Others), By Region, Forecast & Opportunities, 2026”, has evaluated the future growth potential of the global coronavirus testing kits market and provides statistics and information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in the global coronavirus testing kits market.

Browse Related Reports:

Global Coronavirus Diagnostics Market By Type of Test (Molecular v/s Serological), By User (Single v/s Multiple), By Full Test Time (Less Than 60 Minutes, 1 Hour - 12 Hours, 13 Hours - 24 Hours, More Than 1 Day), By End User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Others), By Region, Competition, Forecast & Opportunities, 2025

https://www.techsciresearch.com/report/coronavirus-diagnostics-market/4574.html

Global Virus Testing Kits Market By Test Type (DFA, Polymerase Chain Reaction (PCR)-Based Tests, Agglutination Assays, Solid-Phase Assays, Others), By Virus Type (Coronavirus, Influenza, Hepatitis, HIV, Measles, Smallpox, Dengue, Ebola, Rota Virus, SARS, MERS, Others), By Genetic Information (DNA, RNA), By End User (Diagnostic & Clinical Laboratories, Academic & Research Institutes, Contract Research Organizations, And Others), By Region, Forecast & Opportunities, 2025

https://www.techsciresearch.com/report/virus-testing-kits-market/4596.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

#TechSci #Market Research Reports #Global Coronavirus Testing Kits Market #Coronavirus Testing Kits Market #Coronavirus Testing Kits Market Size #Healthcare #Medical Devices #Coronavirus Testing Kits Market Forecast

0 notes

techsciresearch · 4 years ago

Text

Europe to Dominate Coronavirus Testing Kits Market until 2026 | TechSci Research

Growing cases of COVID-19 disease across the globe to drive the growth of global coronavirus testing kits market.

Browse 247 Figures spread through 110 Pages and an in-depth TOC on "Global Coronavirus Testing Kits Market"

https://www.techsciresearch.com/report/coronavirus-testing-kits-market/4693.html

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4693

Customers can also request for 10% free customization on this report.

Browse Related Reports:

https://www.techsciresearch.com/report/coronavirus-diagnostics-market/4574.html

https://www.techsciresearch.com/report/virus-testing-kits-market/4596.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

0 notes